ARTICLE | Clinical News

Eviplera regulatory update

February 20, 2012 8:00 AM UTC

The Scottish Medicines Consortium recommended the use of Eviplera emtricitabine/tenofovir/rilpivirine on the National Health Service (NHS) in Scotland to treat HIV-1 infection in antiretroviral treatment-naïve adults with a viral load <=100,000 HIV-1 RNA copies/mL - its approved indication. The consortium said the combination tablet has been shown to be bioequivalent to the individual components given separately and is available at pro rata cost to the individual components. ...